Latest / EMJ Podcast: Insights For Healthcare Professionals
AMJ Podcast | Episode 10 | Navigating BPDCN: Bridging Clinical Heterogeneity and Treatment Evidence with Tagraxofusp
This episode was funded by Stemline Therapeutics, Inc., a Menarini Company Group, and is intended for United States healthcare professionals only.
The opinions expressed here are solely those of the named speaker and do not represent those of his affiliated institution.
His participation in this discussion does not constitute, and should not be construed as, endorsement, recommendation, or promotion of any product, service, or organization.
In this podcast, we shine a light on blastic plasmacytoid dendritic cell neoplasm (BPDCN), a rare and highly aggressive hematologic malignancy.
Before…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.